• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

作者信息

Filetti S, Durante C, Hartl D, Leboulleux S, Locati L D, Newbold K, Papotti M G, Berruti A

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Department of Head and Neck Oncology, Gustave Roussy, Villejuif; Université Paris Saclay, Villejuif.

出版信息

Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400.

DOI:10.1093/annonc/mdz400
PMID:31549998
Abstract
摘要

相似文献

1
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.甲状腺癌：ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400.
2
Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.甲状腺癌：风险分层管理与个体化治疗。
Clin Cancer Res. 2016 Oct 15;22(20):5012-5021. doi: 10.1158/1078-0432.CCR-16-0484.
3
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.甲状腺癌中酪氨酸激酶抑制剂的分子靶点。
Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26.
4
Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.滤泡状癌、乳头状癌和髓样甲状腺癌远处转移的风险模式
Horm Metab Res. 2022 Jan;54(1):7-11. doi: 10.1055/a-1668-0094. Epub 2021 Nov 10.
5
Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning.深度学习辅助下的甲状腺术中冰冻切片病变的病理学诊断。
BMC Cancer. 2024 Aug 29;24(1):1069. doi: 10.1186/s12885-024-12849-8.
6
Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.在日本的一项单机构研究中，既往诊断为滤泡性腺瘤的肿瘤中，具有甲状腺滤泡状肿瘤乳头状核特征的非侵袭性滤泡性甲状腺肿瘤的流行率和诊断意义。
Endocr J. 2020 Oct 28;67(10):1071-1075. doi: 10.1507/endocrj.EJ20-0198. Epub 2020 Jun 26.
7
The changing incidence of thyroid cancer.甲状腺癌发病率的变化
Nat Rev Endocrinol. 2016 Nov;12(11):646-653. doi: 10.1038/nrendo.2016.110. Epub 2016 Jul 15.
8
Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.随机比较 1.1GBq 和 3.7GBq 放射性碘消融治疗低危甲状腺癌：13 年随访。
Acta Oncol. 2020 Sep;59(9):1064-1071. doi: 10.1080/0284186X.2020.1785003. Epub 2020 Jun 30.
9
Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.农村人口甲状腺癌发病率的地理空间与时间分析
Thyroid. 2015 Jul;25(7):812-22. doi: 10.1089/thy.2015.0039. Epub 2015 Jun 2.
10
Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.小儿甲状腺癌：遗传学、治疗和预后。
Endocrinol Metab Clin North Am. 2020 Dec;49(4):589-611. doi: 10.1016/j.ecl.2020.08.001. Epub 2020 Oct 14.

引用本文的文献

1
Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis.解析甲状腺癌发病率上升的原因并应对过度诊断问题。
Nat Rev Endocrinol. 2025 Sep 3. doi: 10.1038/s41574-025-01168-y.
2
GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC.去泛素化酶USP8稳定的GPR34抑制甲状腺未分化癌的铁死亡
Mediators Inflamm. 2025 Aug 18;2025:5576056. doi: 10.1155/mi/5576056. eCollection 2025.
3
Comparison of incidentally detected focal FDG uptake in the thyroid gland on PET/CT with fine needle aspiration biopsy results.
PET/CT上甲状腺内偶然发现的局灶性FDG摄取与细针穿刺活检结果的比较。
Saudi Med J. 2025 Aug;46(8):913-918. doi: 10.15537/smj.2025.46.8.20241077.
4
Long non-coding RNA NR2F1-AS1: an increasingly significant LncRNA in human cancers.长链非编码RNA NR2F1-AS1：一种在人类癌症中日益重要的长链非编码RNA。
J Physiol Biochem. 2025 Aug 19. doi: 10.1007/s13105-025-01119-1.
5
La-related protein 1 drives malignant progression and epithelial-mesenchymal transition in anaplastic thyroid carcinoma.La相关蛋白1驱动间变性甲状腺癌的恶性进展和上皮-间质转化。
Am J Cancer Res. 2025 Jul 15;15(7):2988-3002. doi: 10.62347/GUPU2399. eCollection 2025.
6
A Model Predicting Occult Metastases in Lateral Lymph Nodes in pN1a Stage Papillary Thyroid Cancer.预测pN1a期乳头状甲状腺癌侧方淋巴结隐匿性转移的模型
Int J Gen Med. 2025 Aug 6;18:4279-4290. doi: 10.2147/IJGM.S528876. eCollection 2025.
7
Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma.磷酸甘油酸激酶1作为甲状腺乳头状癌潜在的预后生物标志物
Front Pharmacol. 2025 Jul 23;16:1542159. doi: 10.3389/fphar.2025.1542159. eCollection 2025.
8
Neoadjuvant therapy and surgical resection successfully treating primary thyroid squamous cell carcinoma: a case report.新辅助治疗与手术切除成功治疗原发性甲状腺鳞状细胞癌：一例报告
Gland Surg. 2025 Jul 31;14(7):1399-1405. doi: 10.21037/gs-2025-88. Epub 2025 Jul 28.
9
Synchronous occurrence of papillary thyroid carcinoma and medullary thyroid carcinoma in the setting of Hashimoto's thyroiditis: a case report with literature review.桥本甲状腺炎背景下甲状腺乳头状癌与甲状腺髓样癌的同步发生：一例病例报告并文献复习
Gland Surg. 2025 Jul 31;14(7):1406-1414. doi: 10.21037/gs-2025-141. Epub 2025 Jul 28.
10
The central lymph node dissection using carbon nanoparticle in transoral vestibular approach endoscopic thyroid surgery.经口前庭入路内镜甲状腺手术中使用碳纳米颗粒进行中央淋巴结清扫术。
Sci Rep. 2025 Aug 3;15(1):28320. doi: 10.1038/s41598-025-14219-1.